A Novel Germline Heterozygous


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 01 10 2021
accepted: 02 11 2021
entrez: 10 12 2021
pubmed: 11 12 2021
medline: 17 2 2022
Statut: epublish

Résumé

B-cell lymphoma/leukemia 11B (BCL11B) is a C

Identifiants

pubmed: 34887873
doi: 10.3389/fimmu.2021.788278
pmc: PMC8650153
doi:

Substances chimiques

BCL11B protein, human 0
Repressor Proteins 0
Tumor Suppressor Proteins 0
Zebrafish Proteins 0

Types de publication

Case Reports Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

788278

Subventions

Organisme : NIAID NIH HHS
ID : P01 AI138962
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA006927
Pays : United States
Organisme : CIHR
Pays : Canada

Informations de copyright

Copyright © 2021 Lu, Sertori, Contreras, Hamer, Messing, Del Bel, Lopez-Rangel, Chan, Rehmus, Milner, McNagny, Lehman, Wiest and Turvey.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Blood Adv. 2020 Jun 23;4(12):2611-2616
pubmed: 32556283
Nat Methods. 2016 Feb;13(2):109-10
pubmed: 26820543
Brain. 2018 Aug 1;141(8):2299-2311
pubmed: 29985992
J Allergy Clin Immunol. 2007 Feb;119(2):280-94; quiz 295-6
pubmed: 17291848
Annu Rev Immunol. 2020 Apr 26;38:785-808
pubmed: 32126183
N Engl J Med. 2016 Dec;375(22):2165-2176
pubmed: 27959755
Nat Commun. 2018 Apr 26;9(1):1679
pubmed: 29700302
J Immunol. 2014 Sep 1;193(5):2059-65
pubmed: 25128552
Cell Res. 2019 Nov;29(11):960-963
pubmed: 31467406
Front Immunol. 2021 Apr 14;12:669498
pubmed: 33936112
Nucleic Acids Res. 2018 Jan 4;46(D1):D1039-D1048
pubmed: 29112736
Front Cell Dev Biol. 2020 Dec 10;8:581674
pubmed: 33363142
Nat Med. 2014 Sep;20(9):1043-9
pubmed: 25129481

Auteurs

Henry Y Lu (HY)

Department of Pediatrics, British Columbia Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.
Experimental Medicine Program, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.

Robert Sertori (R)

Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA, United States.

Alejandra V Contreras (AV)

Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA, United States.

Mark Hamer (M)

Biomedical Research Centre, The University of British Columbia, Vancouver, BC, Canada.

Melina Messing (M)

Experimental Medicine Program, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.
Biomedical Research Centre, The University of British Columbia, Vancouver, BC, Canada.

Kate L Del Bel (KL)

Department of Pediatrics, British Columbia Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.

Elena Lopez-Rangel (E)

Department of Pediatrics, British Columbia Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.

Edmond S Chan (ES)

Department of Pediatrics, British Columbia Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.

Wingfield Rehmus (W)

Department of Pediatrics, British Columbia Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.

Joshua D Milner (JD)

Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, United States.

Kelly M McNagny (KM)

Biomedical Research Centre, The University of British Columbia, Vancouver, BC, Canada.
Department of Medical Genetics, The University of British Columbia, Vancouver, BC, Canada.

Anna Lehman (A)

Department of Medical Genetics, The University of British Columbia, Vancouver, BC, Canada.

David L Wiest (DL)

Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA, United States.

Stuart E Turvey (SE)

Department of Pediatrics, British Columbia Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.
Experimental Medicine Program, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH